"The conversion rate with The Swarm is miles ahead of cold outreach. Knowing we have a warm connection increases trust and momentum, making enterprise deals happen much faster."
Gabriel Koslover, Growth Lead, US, at uMed

Challenge

uMed, a healthtech platform focused on Real-World Evidence (RWE) for pharmaceutical companies, was seeking to optimize their referrals and relationship-based outreach. Their manual research and outreach strategy through LinkedIn was time-consuming, lacked precision, and offered no insight into the strength of their connections. As a result, it wasn't scalable and the team struggled with convincing board members and investors to actively make introductions due to process friction.

Solution

uMed selected The Swarm to solve two key pain points:

1. Streamline intro mapping and outreach to high-value connections including investors, board members, company executives, and key external stakeholders.
2. Optimize investor introductions to accelerate their next fundraising round.

Overall, The Swarm’s AI Network Mapper stood out because it allowed uMed to access board members’ and investors' work networks without requiring them to manually sign up initially. This feature eliminated friction, saving time and increasing engagement.

The Swarm for Business Development

uMed piloted The Swarm’s platform with five key contacts, including their chairperson and two board members. Using The Swarm’s AI Network Mapper, they identified target connections within pharmaceutical companies focused on RWE. They identified strong connections and reached out for personalized introductions.

• Result: 4 introductions secured → 2 turned into high-quality opportunities → 1 already advanced to a $250K proposal stage.
• Impact: Conversion rates from calls to opportunities increased significantly with introductions, compared to traditional outbound emails.

The Swarm for Fundraising

In parallel, uMed used The Swarm to expand their investor reach through warm intros. Initially, they relied on asking their investors to think of intros they could make. With The Swarm, they were proactive in identifying at least three additional relevant funds through their investors' networks, prompting introductions that wouldn’t have occurred otherwise.

• Result: Two new investor meetings secured, with one advancing to the due diligence stage.
• Impact: Expanded investor outreach beyond the original list, ensuring no stone was left unturned.

Gabriel shared: "Our investors initially doubted we’d find new connections they hadn’t thought of. But thanks to The Swarm, we uncovered three new funds—two of which resulted in meetings, and one is now in advanced discussions."

Results

1. Time Savings: uMed reduced research for warm intros and manual outreach efforts from three days to a few hours.
2. Higher Conversion Rates: Introductions facilitated by The Swarm led to more than 2x higher conversion rates compared to cold outreach.
3. Accelerated Fundraising: New investor meetings were secured, helping uMed incrementally with their next fundraising round.

The Swarm enabled uMed to automate and scale relationship-based outreach with a centralized, searchable combined network organized by strength of relationships. By leveraging their extended network, uMed uncovered new opportunities and faster conversions in both business development and fundraising. The platform’s AI Network Mapper feature allowed them to get results without initially inviting people to sign up.

‍

What’s Next?

"The market is shifting towards trusted, relationship-based business development. The Swarm makes scaling that approach easy," said Gabriel.

Following the success of the pilot, uMed plans to expand their use of The Swarm for multi-threading enterprise deals, ensuring buy-in from multiple stakeholders within target organizations.